Warberg Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-73,422
Closed -$777K 222
2026
Q1
$777K Hold
73,422
0.13% 65
2025
Q4
$769K Hold
73,422
0.09% 67
2025
Q3
$759K Sell
73,422
-1,000
-1% -$10.3K 0.12% 67
2025
Q2
$765K Buy
74,422
+2
+0% +$20 0.12% 70
2025
Q1
$750K Buy
+74,420
New +$748K 0.12% 72

Other funds holding TDAC

Warberg Asset Management's TDAC Position: Q2 2026 in Review

Warberg Asset Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 73,422 shares — an estimated $777K sold.

Warberg Asset Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $777K in Q1 2026. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Warberg Asset Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Warberg Asset Management sold 73,422 Translational Development Acquisition Corp shares in Q2 2026, an estimated $777K.
  • Warberg Asset Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Warberg Asset Management's Translational Development Acquisition Corp position peaked at $777K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.